Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the full record of transactions filed by Kelsey Stephen Michael, Autre. Director active across 1 company, notably Revolution Medicines, Inc.. Cumulatively, 38 filings have been published. Breakdown: 0 buy · 25 sells. Total volume traded: €4.3m. History available since 17 June 2021. The latest transaction was disclosed on 17 March 2026 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Kelsey Stephen Michael
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
16,667 shares@ US$29.047213.0% of flowCommon StockSEC:0001610717-23-000309:0
25 of 38 declarations
About Kelsey Stephen Michael
Kelsey Stephen Michael is an other declarant linked to Revolution Medicines, Inc. (XNAS), with 38 filings in total. Across the 38 sampled filings, all transactions are sales, for EUR 4,262,874 in total, between 2021-06-22 and 2026-03-19. The largest sampled filings include EUR 875663.2679106905 on 2023-12-29, EUR 455682.2414841164 on 2023-10-13, EUR 441958.086872074 on 2023-08-03, EUR 403076.4057042897 on 2025-09-15, EUR 372158.0988244604 on 2026-03-19, and EUR 355965.2517879267 on 2025-12-18.